Pharma Journalist -

Abcam plc, a global innovator in life science reagents and tools, and SomaServe Ltd, a Pharma service and specialist reagent business exploiting PolyNaut Technology, have announced a…
Read More...

Dicerna Pharmaceuticals, Inc. announced that the European Commission (EC) has granted orphan drug designation to Dicerna’s DCR-A1AT for the treatment of congenital alpha-1 antitrypsin…
Read More...

Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, and the Sean M.…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA) voted 9-4 in favor…
Read More...

Shandong Fontacea Pharmaceutical Co. Ltd. announced that it has entered into an exclusive license, development and commercialization agreement with Janssen Biotech, Inc., to develop and…
Read More...

BioArctic AB (publ) announced the initiation of a research collaboration with Eisai aimed at further studying the unique profile of the investigational drug candidate BAN2401. The…
Read More...

Triplet Therapeutics, Inc., a biotechnology company harnessing human genetics to develop treatments for repeat expansion disorders at their source, launched today with $59 million in…
Read More...

CytoDyn Inc. and Vyera Pharmaceuticals, LLC announced that they have entered into a Commercialization and License Agreement (CLA) and a related Supply Agreement to commercialize…
Read More...

Roche and Spark Therapeutics, Inc. announced the completion of the acquisition following the receipt of regulatory approval from all government authorities required by the merger…
Read More...

AstraZeneca and MSD Inc., Kenilworth, NJ, US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced that the US Food and Drug Administration (FDA) Oncologic Drugs…
Read More...